Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library. 2016

Han Wang, and Rui Yu, and Ting Fang, and Ting Yu, and Xiangyang Chi, and Xiaopeng Zhang, and Shuling Liu, and Ling Fu, and Changming Yu, and Wei Chen
Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, Beijing 100071, China. happywanghan@163.com.

Tetanus neurotoxin (TeNT) produced by Clostridium tetani is one of the most poisonous protein substances. Neutralizing antibodies against TeNT can effectively prevent and cure toxicosis. Using purified Hc fragments of TeNT (TeNT-Hc) as an antigen, three specific neutralizing antibody clones recognizing different epitopes were selected from a human immune scFv antibody phage display library. The three antibodies (2-7G, 2-2D, and S-4-7H) can effectively inhibit the binding between TeNT-Hc and differentiated PC-12 cells in vitro. Moreover, 2-7G inhibited TeNT-Hc binding to the receptor via carbohydrate-binding sites of the W pocket while 2-2D and S-4-7H inhibited binding of the R pocket. Although no single mAb completely protected mice from the toxin, they could both prolong survival when challenged with 20 LD50s (50% of the lethal dose) of TeNT. When used together, the mAbs completely neutralized 1000 LD50s/mg Ab, indicating their high neutralizing potency in vivo. Antibodies recognizing different carbohydrate-binding pockets could have higher synergistic toxin neutralization activities than those that recognize the same pockets. These results could lead to further production of neutralizing antibody drugs against TeNT and indicate that using TeNT-Hc as an antigen for screening human antibodies for TeNT intoxication therapy from human immune antibody library was convenient and effective.

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000915 Antibody Affinity A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes. Affinity, Antibody,Antibody Avidity,Avidity, Antibody,Affinities, Antibody,Antibody Affinities,Antibody Avidities,Avidities, Antibody

Related Publications

Han Wang, and Rui Yu, and Ting Fang, and Ting Yu, and Xiangyang Chi, and Xiaopeng Zhang, and Shuling Liu, and Ling Fu, and Changming Yu, and Wei Chen
January 2012, Virus research,
Han Wang, and Rui Yu, and Ting Fang, and Ting Yu, and Xiangyang Chi, and Xiaopeng Zhang, and Shuling Liu, and Ling Fu, and Changming Yu, and Wei Chen
April 2019, Journal of microbiology and biotechnology,
Han Wang, and Rui Yu, and Ting Fang, and Ting Yu, and Xiangyang Chi, and Xiaopeng Zhang, and Shuling Liu, and Ling Fu, and Changming Yu, and Wei Chen
December 2009, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
Han Wang, and Rui Yu, and Ting Fang, and Ting Yu, and Xiangyang Chi, and Xiaopeng Zhang, and Shuling Liu, and Ling Fu, and Changming Yu, and Wei Chen
August 1998, Nature biotechnology,
Han Wang, and Rui Yu, and Ting Fang, and Ting Yu, and Xiangyang Chi, and Xiaopeng Zhang, and Shuling Liu, and Ling Fu, and Changming Yu, and Wei Chen
July 2005, World journal of gastroenterology,
Han Wang, and Rui Yu, and Ting Fang, and Ting Yu, and Xiangyang Chi, and Xiaopeng Zhang, and Shuling Liu, and Ling Fu, and Changming Yu, and Wei Chen
October 2015, Protein engineering, design & selection : PEDS,
Han Wang, and Rui Yu, and Ting Fang, and Ting Yu, and Xiangyang Chi, and Xiaopeng Zhang, and Shuling Liu, and Ling Fu, and Changming Yu, and Wei Chen
March 1996, The Journal of biological chemistry,
Han Wang, and Rui Yu, and Ting Fang, and Ting Yu, and Xiangyang Chi, and Xiaopeng Zhang, and Shuling Liu, and Ling Fu, and Changming Yu, and Wei Chen
April 2000, Scandinavian journal of immunology,
Han Wang, and Rui Yu, and Ting Fang, and Ting Yu, and Xiangyang Chi, and Xiaopeng Zhang, and Shuling Liu, and Ling Fu, and Changming Yu, and Wei Chen
January 2017, Life sciences,
Han Wang, and Rui Yu, and Ting Fang, and Ting Yu, and Xiangyang Chi, and Xiaopeng Zhang, and Shuling Liu, and Ling Fu, and Changming Yu, and Wei Chen
September 1994, British journal of haematology,
Copied contents to your clipboard!